Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 1/20 | 0.59 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.59 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.59 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 16/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8094698 | 0.93 | MAPK13 (0.53) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8094384 | 0.90 | MAPK13 (0.47) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8087346 | 0.89 | MAPK13 (0.48) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8101739 | 0.89 | MAPK13 (0.54) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8086624 | 0.86 | PTGS2 (0.56) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8085735 | 0.86 | PTGS2 (0.52) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8095596 | 0.86 | PTGS2 (0.46) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8099392 | 0.86 | PTGS2 (0.50) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8092688 | 0.84 | MAPK13 (0.43) | MAPK13MAPK12MAPK11MAPK14PTGS2 | |
| SCHEMBL8099590 | 0.83 | PTGS2 (0.54) | MAPK13MAPK12MAPK11MAPK14PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | disclosed |
| US-5916905-A | ANTIARTHRITIC AGENTS; ANALGESICS; ANTIPYRETICS | G. D. SEARLE & CO. (US) | 1999-06-29 | — | — | US | disclosed |
| EP-0808304-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-11-26 | — | — | EP | disclosed |
| US-5686470-A | 2, 3-substituted pyridines for the treatment of inflammation | WEIER RICHARD M (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996024584-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | disclosed |